medac CDMO Capabilities Update March 2026: Fill/Finish

With more than 25 years of proven sterile manufacturing expertise, medac CDMO brings deep technical maturity to the development and production of complex injectable therapies. Our team supports a wide range of parenteral formats —including prefilled syringes, high‑potency vials, and ADC fill‑and‑finish — designed to meet the evolving needs of modern drug programs. This presentation examines how a strategically designed European manufacturing footprint strengthens scale‑up predictability, enhances operational flexibility, and reinforces supply reliability for global markets.

Attendees will gain insight into the infrastructure, process design, and quality systems that underpin dependable performance across both clinical and commercial phases. Discussion will highlight how an integrated setup helps programs maintain continuity despite shifting market conditions, capacity constraints, or regulatory expectations. For organizations advancing complex injectable portfolios, this session provides a practical look at how a purpose‑built sterile manufacturing model can support consistent, long‑term success.

Access the full presentation to explore best practices and real‑world considerations for building a resilient and scalable injectable supply strategy.